UNSPSC 51284501: Lincomycin

This classification denotes a lincosamide antibiotic with the molecular formula C18H34N2O6S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier BOD072YW0F, chemically known as lincolnensin, hydrochloride, hemihydrate but generally known as lincomycin, which bears US NIH Compound Identifier 3928. European Medicines Agency schedules Lincomycin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08517MIG.

UNSPSC 51284501 Lincomycin, a Commodity code, does not align with the recent state and local procurement activity tagged under it. The code nominally describes a specific antibiotic pharmaceutical, but the four recent opportunities posted under this code solicit naloxone and drug deactivation systems, therapeutic pharmacy initiatives, medical and first aid supplies for fire rescue, and generic multi-source pharmaceuticals and OTC products — none of which are lincomycin. The mismatch suggests a classification error in the state and local procurement systems, and the code shows little relevant recent activity for lincomycin itself.

The issuing bodies across these opportunities span county health departments, state health and human services agencies, municipal fire departments, and multistate cooperative purchasing alliances. Seminole County, Florida (IFB60459723LAS, due July 26, 2023) sought 1,900 units of naloxone and 800 safe drug deactivation systems annually for the Seminole County Community Health Building; the Texas Health and Human Services Commission (HHS0017013, posted April 3, 2026) issued an RFI on direct-to-manufacturer prescription programs; the City of Tampa (26P00145, due March 13, 2026) solicited medical and first aid supplies for the Tampa Fire Department Rescue Division under a Small Local Business Enterprise set-aside; and the Minnesota Multistate Cooperative Purchasing Alliance (S1070000015802, due March 26, 2026) sought generic multi-source pharmaceuticals and OTC products through authorized wholesalers. Geographic activity appears concentrated in Florida, Texas, Minnesota, and Oregon, though the classification error limits confidence in the actual market for lincomycin specifically.